Holen Sie sich die Stockscreener-App
1.69
4.52%
-0.08
Handel nachbörslich:
1.69
Geron Corp Aktie (GERN) Neueste Nachrichten
Geron (GERN) grants 2.5M stock options to chief legal officer - Stock Titan
Geron (GERN) EVP and Chief Legal Officer files initial Form 3 insider report - Stock Titan
Geron Corp stock (US3741631036): Is imetelstat approval the real test for biotech upside? - AD HOC NEWS
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Geron Highlights RYTELO Launch, 2026 Revenue Outlook and Phase 3 Myelofibrosis Plans at Needham Conf - Yahoo Finance
Geron names Timothy Williams as chief legal officer By Investing.com - Investing.com South Africa
Geron names Timothy Williams as chief legal officer - Investing.com
Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary - ChartMill
Geron Corp stock (US3741631036): Is imetelstat approval the real test for biotech investors now? - AD HOC NEWS
History Review: Can Geron Corporation be the next market leader2026 Key Lessons & Risk Managed Investment Signals - baoquankhu1.vn
GERN Stock Price, Quote & Chart | GERON CORP (NASDAQ:GERN) - ChartMill
Board agenda in new Geron (NASDAQ: GERN) 2026 virtual annual meeting proxy - Stock Titan
Geron Corporation (GERN) stock price, news, quote and history - Yahoo Finance UK
Geron Corporation (GERN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Form DEF 14AOther definitive proxy statements - ADVFN
Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference - The Manila Times
Geron executives to speak April 13 at Needham healthcare webcast - Stock Titan
Is Geron (GERN) Quietly Reframing Its Oncology Commercialization Strategy With New Board Appointments? - simplywall.st
GERN News | GERON CORP (NASDAQ:GERN) - ChartMill
Geron (NASDAQ:GERN) Trading Up 9.7%What's Next? - MarketBeat
Geron Corporation’s Strategic Moves Amplify Stocks in Q1 2026 - StocksToTrade
Geron (GERN) director receives 5,243-share stock grant for board compensation - Stock Titan
Market Recap: Can Geron Corporation deliver consistent dividendsPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Geron (NASDAQ:GERN) Share Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
Aug Highlights: Can Geron Corporation be the next market leaderExit Point & Breakout Confirmation Trade Signals - baoquankhu1.vn
GERN Technical Analysis | Trend, Signals & Chart Patterns | GERON CORP (NASDAQ:GERN) - ChartMill
Geron Corp Stock: Biotech Investor Focus on RYTELO Commercialization and Valuation Gap Amid Market V - AD HOC NEWS
Geron Adds Biopharma Veterans As RYTELO Focus And Valuation Draw Attention - Yahoo Finance
GERN SEC FilingsGeron Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Assessing Geron (GERN) Valuation After Recent Share Price Weakness - simplywall.st
Geron Adds Biopharma Veterans As RYTELO Commercialization And Valuation Scrutinized - simplywall.st
Vanguard (NASDAQ: GERN) discloses 0 share ownership after realignment - Stock Titan
Geron Corporation Form 8-K Filing Details for March 25, 2026: Company Information, Stock Symbol, and SEC Compliance 16 - Minichart
Geron (NASDAQ: GERN) director granted 270,000 stock options at $1.57 strike - Stock Titan
Geron (GERN) director Constantine Chinoporos files initial Form 3 - stocktitan.net
Geron (GERN) grants director 270,000 stock options at $1.57 - Stock Titan
Geron (GERN) director Patricia Andrews submits initial insider ownership filing - Stock Titan
Geron appoints Patricia S. Andrews and Constantine Chinoporos to board of directors - Investing.com
Geron adds two directors with commercial expertise to board - Investing.com
[8-K] GERON CORP Reports Material Event - Stock Titan
Geron Announces Appointment of New Members to its Board of Directors - ChartMill
Geron Corp stock advances on imetelstat FDA approval momentum and pipeline updates - AD HOC NEWS
Geron's cancer screening patent rejected as non-patentable under Indian law - MLex
Geron (NASDAQ:GERN) Trading Up 8.6%Here's What Happened - MarketBeat
Geron’s Strategic Push: RYTELO’s Rising Global Ambitions - StocksToTrade
Levi & Korsinsky Notifies Shareholders of Geron Corporation(GERN) - The National Law Review
Geron Corporation (NASDAQ:GERN) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Six new Geron hires get stock options on 956,250 shares - Stock Titan
Geron (GERN) reports Q4 loss, misses revenue estimates - MSN
Geron Details RYTELO Growth Plan, $220M-$240M 2026 Sales Guide and MF Trial Catalyst at Barclays Conference - MarketBeat
Geron (NASDAQ:GERN) Shares Up 8.5%Should You Buy? - MarketBeat
Almitas Capital LLC Buys Shares of 946,323 Geron Corporation $GERN - MarketBeat
Geron (NASDAQ:GERN) Stock Price Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Geron Corporation (GERN) Reports Q4 EPS of (5c) - Insider Monkey
Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans - Investing.com
How The Geron (GERN) Story Is Shifting After Target Cut And New Equity Plans - Yahoo Finance
11 Fastest Growing Penny Stocks to Buy Right Now - Insider Monkey
Geron Earnings Call: Rytelo Growth Amid Profit Pressures - TipRanks
Geron Empowers Expansion with Rytelo’s Fuel - StocksToTrade
Geron (NASDAQ:GERN) Trading Up 10.9%Here's What Happened - MarketBeat
Geron Corporation $GERN Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):